Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis VIRP

Max Ratio

Dividend Yield

0.78 %

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

6.21 %

Dividend History VIRP

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.78 %
Consecutive Years 0
Forward Annual Dividend 2.77 EUR
Consistent Years 4
Dividend CAGR 3Y 20.74 %
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM 8.36 %
Dividend CAGR 10Y
Ex Dividend Date 06/24/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth VIRP

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin VIRP

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income VIRP

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM VIRP

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio VIRP

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Virbac SA VIRP

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself VIRP

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 22.45
Forward PE 17.83
Enterprise Value Revenue 2.22
Price Sales TTM 2.08
Enterprise Value EBITDA 12.05
Price Book MRQ 2.80

Virbac SA Dividends: 0.41 % Yield, History, Payment Schedule

VIRP
Current price
356.00 EUR -0.5 EUR (-0.14%)
Last closed 356.50 EUR
ISIN FR0000031577
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Euronext Paris
Capitalization 2 989 085 635 EUR
Yield for 12 month +11.60 %
1Y
3Y
5Y
10Y
15Y
VIRP
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+1 400 462 974 EUR

Last Year

+1 249 651 980 EUR

Current Quarter

+739 904 824 EUR

Last Quarter

+695 979 126 EUR

Current Year

+939 672 591 EUR

Last Year

+811 384 179 EUR

Current Quarter

+498 517 434 EUR

Last Quarter

+455 792 379 EUR
EBITDA 262 996 961 EUR
Operating Margin TTM 17.92 %
Price to Earnings 22.45
Return On Assets TTM 7.35 %
PEG Ratio
Return On Equity TTM 12.93 %
Wall Street Target Price 346.17 EUR
Revenue TTM 1 435 883 894 EUR
Book Value 127.41 EUR
Revenue Per Share TTM
Dividend Share 1.45 EUR
Quarterly Revenue Growth YOY 5.00 %
Dividend Yield 0.78 %
Gross Profit TTM 957 976 919 EUR
Earnings per share 15.89 EUR
Diluted Eps TTM 15.89 EUR
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY -12.90 %
Profit Margin 9.29 %

Technical Indicators VIRP

For 52 Weeks

249.13 EUR 372.32 EUR
50 Day MA 342.31 EUR
Shares Short Prior Month
200 Day MA 326.20 EUR
Short Ratio
Shares Short
Short Percent